Peptide 234CM

Peptide 234CM, containing an isoleucine substitution at position 3, corresponds to a mutant p53 codon 234 sequence. This immunogenic peptide is used in cancer immunotherapy research to induce cytotoxic T lymphocytes (CTL) and study antitumor responses in both in vitro and in vivo experimental models.